Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | GENI | EVCM |
|---|---|---|
| Price | $5.99 | $9.07 |
| Change today | ▼ 0.50% | ▲ 1.45% |
| Market cap | $1.60B | $1.60B |
| Return, 3 months | -7.4% | -9.9% |
| Return, year to date | -45.6% | -25.1% |
| Return, 1 year | -49.2% | -20.4% |
| P/E (TTM) | -8.9 | 47.7 |
| P/B | 2.3 | 2.2 |
| P/E percentile vs own 5y | 56th | 82nd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +74.5% | +23.2% |
| Analyst buy share | 85% | 50% |
| RSI (14) | 42 | 55 |
| 30-day volatility | 74.6% | 96.8% |
| Max drawdown, 1 year | -70.8% | -52.9% |
| Trend read | Strong downtrend | Leaning bullish |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
